More importantly, Skp2 deletion in a Skp2 knockout mouse model has been shown by multiple groups to markedly restrict tumorigenesis under different conditions of tumor initiation and promotion, including PTEN, ARF, pRB inactivation, as well as HER-2/Neu overexpression [45,46]. This evidence concerns the gene ERBB2 and neoplasm.